Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The GAPP Aggressivity Score Correlates with Total Enriched Somatic Variant Burden in Sporadic Pheochromocytoma-A Pilot Study.

Cancers·2026
Same author

Multiplatform curation in the development of ACMG/AMP specifications for Von Hippel-Lindau (VHL) disease.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Family History Predicts Primary Hyperparathyroidism Regardless of Genetic Predisposition.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

RET Lys666Asn has a low rate of MEN2-related tumors but may be associated with pheochromocytoma.

Hormones (Athens, Greece)·2026
Same author

Pseudohypoxia and family history are key predictors of severe outcomes in hereditary pheochromocytoma and paraganglioma syndromes.

European journal of endocrinology·2026
Same author

Distinct epigenetic aging in sporadic and hereditary neuroendocrine neoplasms.

Clinical epigenetics·2026

Related Experiment Video

Updated: Jun 1, 2025

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

11.9K

Progress report on multiple endocrine neoplasia type 1.

Reut Halperin1,2,3, Amit Tirosh4,5,6

  • 1Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Familial Cancer
|January 18, 2025
PubMed
Summary
This summary is machine-generated.

Multiple endocrine neoplasia type 1 (MEN1) syndrome requires specialized management for primary hyperparathyroidism and neuroendocrine neoplasms due to high risks and unique disease characteristics. This report details current surveillance and treatment strategies for MEN1 patients.

Keywords:
HyperparathyroidismMENNeuroendocrine tumorsPituitary

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.7K

Related Experiment Videos

Last Updated: Jun 1, 2025

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

11.9K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.7K

Area of Science:

  • Endocrinology
  • Genetics
  • Oncology

Background:

  • Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder linked to MEN1 gene mutations.
  • Patients face high risks of primary hyperparathyroidism (PHPT), pituitary adenomas, and neuroendocrine neoplasms (NENs).
  • MEN1-related mortality is primarily driven by duodenal-pancreatic and thymic NENs.

Purpose of the Study:

  • To provide an overview of current insights into the surveillance and management of MEN1 syndrome.
  • To discuss specific considerations for PHPT and NEN management in MEN1 patients.
  • To explore MEN1-like presentations and future research directions.

Main Methods:

  • Review of current literature and clinical guidelines for MEN1 management.
  • Analysis of differences in managing PHPT and NEN in MEN1 versus sporadic cases.
  • Discussion of surveillance strategies for early detection and intervention.

Main Results:

  • MEN1 management necessitates distinct approaches for PHPT (e.g., near-total parathyroidectomy) and NENs due to multigland involvement and multifocal neoplasms.
  • Lifelong NEN surveillance requires careful planning to balance early detection with minimizing surgical impact.
  • Understanding MEN1-like syndromes with negative genetic workup is crucial.

Conclusions:

  • Effective management of MEN1 syndrome hinges on tailored surveillance and treatment protocols for its diverse endocrine and neoplastic manifestations.
  • Specialized care is essential to mitigate morbidity and mortality associated with MEN1.
  • Further research is needed to refine management strategies and understand atypical presentations.